a change in treatment regimen be require because of very active epileptiform activity during sleep and neuropsychological regression this mean that only patients with very active epileptiform activity and therefore with a need for a change in treatment regimen a clinically indicate will be potentially eligible additionally a prior clinical decision to use clobazam should have be make by the primary epileptologist in order to participate in the study 